The stock of Cooper Companies Inc (NYSE:COO) is a huge mover today! The stock increased 1.45% or $1.89 during the last trading session, hitting $132.23. Cooper Companies Inc (NYSE:COO) has declined 25.42% since May 5, 2015 and is downtrending. It has underperformed by 24.83% the S&P500.
The move comes after 7 months positive chart setup for the $6.34B company. It was reported on Dec, 8 by Barchart.com. We have $206.28 PT which if reached, will make NYSE:COO worth $3.55B more.
Out of 11 analysts covering Cooper (NYSE:COO), 10 rate it “Buy”, 0 “Sell”, while 4 “Hold”. This means 71% are positive. Cooper was the topic in 16 analyst reports since August 26, 2015 according to StockzIntelligence Inc. Piper Jaffray maintained the stock on December 4 with “Overweight” rating.
According to Zacks Investment Research, “The Cooper Companies, Inc., through its principal subsidiaries, develops, manufactures and markets healthcare products. CooperVision markets a range of contact lenses to correct visual defects, specializing in toric lenses that correct astigmatism. The company also markets conventional toric and spherical lenses and lenses for patients with more complex vision disorders. CooperSurgical markets diagnostic products, surgical instruments and accessories to the women’s healthcare market.” Get a free copy of the Zacks research report on Cooper Companies Inc (COO).
The institutional sentiment increased to 1.13 in Q3 2015. Its up 0.21, from 0.92 in 2015Q2. The ratio improved, as 31 funds sold all Cooper Companies Inc shares owned while 121 reduced positions. 45 funds bought stakes while 126 increased positions. They now own 58.18 million shares or 23.43% more from 47.13 million shares in 2015Q2.
Blue Jay Capital Management Llc holds 7.02% of its portfolio in Cooper Companies Inc for 120,000 shares. Nebula Capital Management Lp owns 45,200 shares or 4.54% of their US portfolio. Moreover, Taurus Asset Management Llc has 2.38% invested in the company for 82,655 shares. The Maryland-based Torray Llc has invested 2.37% in the stock. Orbimed Advisors Llc, a New York-based fund reported 1.30 million shares.
Since March 10, 2015, the stock had 0 buys, and 3 sales for $2.78 million net activity. Rubenstein Allan E sold 294 shares worth $44,100. Rosenberg Steven sold 17,500 shares worth $2.62M. Matz Gregory W sold 10,000 shares worth $1.76M. Weiss Robert S sold 67,500 shares worth $12.59M. The insider Bender A Thomas sold 7,000 shares worth $1.30M.
Cooper Companies Inc - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.